Skip to content
Screener

LifeStance Health Group LFST Business Combination Remeasurement Gain Loss On Contingent Consideration

Business Combination Remeasurement Gain Loss On Contingent Consideration at other companies

Iron Mountain logo
Iron MountainIRM
-$41.94M
Absci Corporation logo
Absci CorporationABSI
$1.28M
ODT
Odyssey TherapeuticsODTX
3,500%
ODT
Odyssey TherapeuticsODTX
3,500%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$179K+117%
The RMR Group logo
The RMR GroupRMR
$3.64M-75.0%

Other financials

Income statement

See full
Revenue$435.4M+26.1%
Operating income$30.7M+1,139%
Net income$23.6M+723%
EPS (diluted)$0.06+700%

Balance sheet

See full
Cash & equivalents$225.9M+19.6%
Total debt$474.2M0.0%
Total equity$1.5B+0.2%
Total assets$2.2B+1.6%

Cash flow

See full
Operating cash flow$99.9M+55.2%
CapEx$12.0M+54.7%
Free cash flow$87.9M+55.2%

Valuation

See full
Market cap$4.14B+133%
Enterprise value$4.39B+113%
P/E81.9×
P/S2.6×+1.3×

Profitability

See full
Operating margin4.9%+4.9pp
Net margin3.2%+2.7pp
FCF margin11%+1.9pp

Returns & leverage

See full
Return on equity3.4%+3.0pp
Debt / equity0.3×0.0×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept lfst:BusinessCombinationRemeasurementGainLossOnContingentConsideration.

The source filing: LifeStance Health Group’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338107
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses$404,701$348,261$785,893$679,627
INCOME (LOSS) FROM OPERATIONS$30,653$(2,950)$52,937$(1,346)
OTHER EXPENSE
Loss on remeasurement of contingent consideration(26)(31)
Transaction costs(445)(989)
Interest expense, net(2,632)(2,900)(4,425)(5,973)
Other expense(93)(92)(275)(93)
Total other expense$(3,196)$(2,992)$(5,720)$(6,066)

Item 1. Financial Statements (Unaudited).

FAQ

What is LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
LifeStance Health Group (LFST) reported business combination remeasurement gain loss on contingent consideration of -$26K in Q2 2026.
What is the long-term trend for LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
Over 2 years (2021 to 2025), LifeStance Health Group's business combination remeasurement gain loss on contingent consideration has grown at a -100.0% compound annual growth rate (CAGR), from -$2.61M to $0.
What does business combination remeasurement gain loss on contingent consideration mean?
Business Combination Remeasurement Gain Loss On Contingent Consideration as reported by LifeStance Health Group, Inc. Common Stock.

Ask your AI about LifeStance Health Group's business combination remeasurement gain loss on contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude